To view this email as a web page, click here

   Home

Subscribe

Advertise

 

 

 

 

October 05, 2018

Today's Rundown

Featured Story

Orchard files for $173M IPO to run pivotal gene therapy trials

Orchard Therapeutics has filed to raise $173 million (€150 million) in an IPO. The offering will give the GlaxoSmithKline-backed biotech the means to take three gene therapies through the clinic and onto the market.

Top Stories

European biotech funding on track for record year

The European biotech sector is on track to break its annual funding record, according to BioWorld. After a big third quarter, the total for the first nine months of the year stands at $6.3 billion, putting the region on course to clear the $8 billion bar.

DDF 2018: How do you fix the glut of immunotherapy combo trials?

A bottleneck of immunotherapy clinical trials has put the field’s advancement somewhat on hiatus as researchers and drug companies wait for the next scientific discovery to ignite development, according to panelists at the 2018 FierceBiotech Drug Development Forum.

Nimbus moves up CFO Keiper to CEO spot

Nimbus Therapeutics has promoted finance chief Jeb Keiper to president and CEO, effective immediately, as the former Fierce 15 winner looks to move its programs into clinical development for cancer, autoimmune and metabolic diseases.

Arena preparing for trials of first-in-class heart failure drug

Arena Pharma has a new drug candidate heading for clinical trials next year that it says could be a first-in-class option for decompensated heart failure.

DDF 2018: The key to academic partnerships? Look before you leap

There’s no one-size-fits-all solution when it comes to academic partnerships, but successful ones have one thing in common: communication.

EuroBiotech Report—Roche inks cancer deals, Forbion's €360M fund, U.K. VC soars and Gamida

In this week's EuroBiotech Report, Roche inks back-to-back cancer deals, Forbion closes €360 million fund, U.K. VC soars and more.

FiercePharmaAsia—Nobel-winning science; Legend CAR-T data allegation; Unhappy Takeda alumni

Japanese scientist Tasuku Honjo wins Nobel Prize in medicine for PD-1 research; GenScript calls claims that its Johnson & Johnson-partnered Legend Biotech unit forged key CAR-T data "blatant slander"; some disgruntled Takeda shareholders demand details on the Shire buyout.

Chutes & Ladders—Pfizer CEO Ian Read hands reins to COO Albert Bourla

Pfizer CEO Ian Read hands reins to COO Albert Bourla; Nimbus moves up CFO Jeb Keiper to CEO spot; and Synlogic names Aoife Brennan as permanent CEO. Those moves plus more hirings, firings and retirings throughout the industry.

Enrollment Showcase

Online Graduate Programs Designed for Your Career

Drexel University’s online graduate programs in biomedicine, clinical research, drug discovery, and molecular medicine were developed with working professionals in mind, providing you with the education, practical skills, and competitive edge you need to be successful in your career. Learn more.

Resources

[Research] Linguistic and Cultural Considerations When Implementing a Global BYOD Study

Examine the linguistic and cultural considerations of global eCOA and BYOD.

[Infographic] Flexible. Scalable. Proactive.

Covance FSPx boasts one of the world’s largest dedicated FSP groups in the contract research organization space with ~4200 staff in 60+ countries.

[eBook] Healthcare and Life Sciences - Data Value Chain

Download our new eBook to learn how Healthcare and Life Sciences organizations are taking advantage of solutions from AWS and the AWS Partner Network to obtain value from critical data.

[Case Study] FSP Insourcing – Relationship Growth Built on Results, Trust

Covance FSPx boasts one of the world’s largest dedicated FSP groups in the contract research organization space with ~4200 staff in 60+ countries.

[POCKET GUIDE] 3 Steps To Supercharge Your Literature Search

Go from Search to Full-Text Scientific Papers in a Single Click!

[eBook] Digital Workflows: How to Focus Investment to Cut Costs and Drive Growth

Life sciences companies must immediately identify and realize productivity gains to drive down operational costs—or risk seeing more nimble competitors disappear into the distance. Where to begin?

[Whitepaper] How to Re-Design your Regulatory Capabilities

A top 20 pharma and growing biotech re-engineer regulatory processes.

[Whitepaper] The Future of Pharmacovigilance: Leveraging Technology and Automation

Are automation, big data and artificial intelligence (AI) a key part of your company’s pharmacovigilance strategy? Read this whitepaper to know what they should be!

[eBook] 2018 Weekly Compendium

The Biopharma industry is moving at lightning speed and it can be a challenge to keep pace. Here at Biotech Primer we spend hours each week researching, writing, and editing original content for the Biotech Primer WEEKLY with one goal in mind: to help everyone better understand the latest science and technology driving today’s healthcare industry.

[Webinar] Enabling precision medicine with Tableau and AWS

Inova is using the capabilities of Tableau on AWS to identify biomarkers for personalized treatment intended to improve health outcomes for children.

[Webinar] Build a holistic data management strategy for Life Sciences

Reltio and IQVIA provide holistic data management solutions for traditional pharma, emerging biotech, and consumer health companies, on AWS.

[Webinar] Safeguard your Life Sciences data with Druva and AWS

Life Sciences organizations are embracing cloud-based Master Data Management (MDM) to modernize the organization of critical data.

[eLearning] BIOAVAILABILITY 101

Develop a basic understanding of principles and concepts of bioavailability of oral drugs.

Events

.